retatrutide phase 2 nejm 2023 obesity trial jastreboff Medscape | The investigational triple GLP-1/GIP/glucagon receptor agonist produced significant weight loss and A1c reduction in people Retatrutide Availability & Timeline |

Tirzepatide: Patients lost 20% of their body weight over 72 weeks with 15 mg injections

This results from a tyramine-induced depletion of norepinephrine normally present in the readily releasable vesicle pool, and replacement of vesicular norepinephrine with tyramine (which functions as a false- or pseudo- neurotransmitter), which when released has no effect on postsynaptic adrenergic receptors (Figure 1)

Although overall structural changes in microbial diversity were not detected, significant shifts in the relative abundance of bacterial taxa were observed in C57BL/6 N mice following 28-day exposure to PET NPs (mean size 56 nm

In this local model, the peptide functions a bit like certain foods that boost satiety hormones or stimulate gut-to-brain signals

Epithalon has been studied for its potential effects on melatonin production and pineal gland function